.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Level is stocked at 717 licensed dispensaries across California, New York, and 5 other states, 446 of them in California, with the deepest coverage in Los Angeles, San Diego, Sacramento, San Francisco, and San Jose. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Level’s category mix is highly concentrated, with Capsules holding a 99.68% share while Flower accounts for 0.32%. Capsules contracted by 56.25% year over year and declined 5.86% month over month, while Flower expanded 304.64% month over month from a very small base and has no year-over-year comp. With average price down 23.22% year over year to $15.78 and Capsules averaging $15.76, the mix shift and broad price compression imply that Level is leaning into Capsules volume at lower price points while cautiously testing diversification via a nascent Flower offer.
Despite a 56.11% brand-level sales decline year over year and a 74.69% drop versus 24 months ago, Level holds rank 2 in Capsules in Nevada, indicating category authority even as volumes contract. The 304.64% month-over-month Flower spike alongside a 5.86% Capsules pullback suggests incremental experimentation rather than a pivot, preserving position in Capsules while probing adjacencies for margin or reach. The pattern implies Level’s near-term positioning remains capsule-led, using tactical price resets and limited-category expansion to defend share and stabilize rank while monitoring whether Flower can scale beyond sub-1% share.
Competitive Landscape
Level is #5 in CA Capsules in August 2026, down 1 rank year over year, after peaking at #1 in January 2026 and sliding from #2 three months ago; meanwhile, Emerald Bay Extracts climbed 6 spots year over year to #1 and Breez moved up 2 positions to #2 despite a 25.6% YoY sales decline, indicating Level is losing relative rank share to brands improving placement regardless of mixed sales trends, which implies the brand’s rank trajectory points to heightened pressure on retention and visibility rather than category demand softness.
Notable Products
Level’s Protab - Sativa Extra Strength Tablets 10-Pack (250mg) posted the steepest movement in August 2026 with a -16.2% month-over-month decline while sitting at rank 6, contrasting with Protab - Sativa Profesional Strength Tablet (100mg) at rank 1 on a +49.0% surge. Protab+ - Lights Out Tablets 10-Pack (50mg CBN, 20mg CBG, 200mg Delta-9 THC, 50mg Delta-8 THC, 20mg THCA) advanced to rank 4 on +27.5%, and Hashtab 100 - Sativa Tablet (100mg) at rank 5 rose +36.8%, indicating movement skewed toward sativa and multi-cannabinoid formats. With all top-10 items concentrated in Capsules and four of the top six either Sativa or multi-cannabinoid propositions, the mix implies Level is consolidating around high-potency capsule use cases rather than broadening into new form factors, even as one high-dose Sativa SKU retrenches.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
